Advances in AI and precision engineering are driving rapid innovation in infertility devices, while favorable reimbursement policies in developed regions boost adoption. Strategic investments in emerging markets are reshaping the competitive landscape and unlocking new market opportunities.

Infertility Devices Market is estimated to be valued at USD 11,969.3 Mn in 2025 and is expected to reach USD 21,462.3 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Infertility Devices Market Forecast underscores growth driven by enhanced R&D, supportive regulatory frameworks, and rising incidence of infertility. These market insights reflect our proprietary market research and highlight evolving market dynamics, market drivers, and market restraints in the industry.



Key Takeaways:

- Dominating Region (2025):

• North America retained the largest industry share due to high adoption of advanced IVF platforms and CMS reimbursement expansions in the U.S. in 2024.

- Fastest Growing Region (2025):

• Asia Pacific exhibited the highest CAGR, propelled by China's national fertility program funding and India's network of specialized fertility hospitals launched in 2025.

- Product Segment:

• Dominant Sub-segment: IVF equipment—Vitrolife's EmbryoScope time-lapse incubator launch in early 2025 strengthened its market share.

• Fastest-growing Sub-segment: ICSI devices—Thermo Fisher's FDA-cleared microinjection platform rolled out in late 2024 saw rapid uptake in North America.

- End-User Segment:

• Dominant Sub-segment: Fertility clinics—Carl Zeiss Meditec AG's partnership with leading U.S. clinics in 2024 drove business growth.

• Fastest-growing Sub-segment: Hospitals—Multi-specialty hospitals in China and South Korea added dedicated reproductive units in 2025, accelerating adoption.



Market Key Trends

A pivotal trend reshaping the Infertility Devices Market revolves around AI-driven embryo selection systems. In mid-2024, Vitrolife introduced its EmbryoViewer AI module, leveraging deep-learning algorithms to enhance embryo viability scoring with 92% accuracy, according to a clinical study published by a leading U.S. fertility center. This aligns with the FDA's 2025 guidance approving algorithm-based decision support for IVF labs, marking a major regulatory milestone. Consequently, IVF clinics are investing in integrated AI platforms to reduce time to pregnancy and improve live-birth rates. Market research indicates that clinics deploying AI-enabled incubators reported a 15% improvement in selection outcomes versus traditional microscopy. This trend underscores a shift towards digital transformation in infertility care, with vendors collaborating with software firms to refine predictive models and ensure seamless integration into existing workflows. The emphasis on AI technology demonstrates significant growth opportunities within the Infertility Devices Market for device manufacturers focused on software-hardware convergence.

Key Players

• Carl Zeiss Meditec AG

• Thermo Fisher Scientific Inc.

• Vitrolife AB

• Cook Medical

• CooperSurgical Inc.

• GE Healthcare

• FUJIFILM Irvine Scientific

• Hamilton Thorne Ltd.

• Irvine Scientific

• Merck KGaA

• Artiste Surgical Ltd.

• Tecan Group AG



Strategies Adopted by Key Players:

• In 2025, Thermo Fisher Scientific forged a strategic partnership with a leading U.S. fertility network to co-develop point-of-care embryo assessment kits, resulting in a 12% uplift in first-cycle success rates.

• Vitrolife expanded its manufacturing footprint in Shanghai in 2024, doubling output capacity for time-lapse incubators and achieving a 20% reduction in lead times across Asia Pacific.

• Carl Zeiss Meditec AG launched a digital-workflow solution integrated with AI analytics in 2024, enhancing its market position by securing service contracts with five top European IVF centers.



FAQs

1. Who are the dominant players in the Infertility Devices Market?

The market is led by companies such as Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., and Vitrolife AB, supported by extensive R&D investments and strategic collaborations.



2. What will be the size of the Infertility Devices Market in the coming years?

Based on our proprietary market forecast, the Infertility Devices Market is projected to reach approximately USD 21,519.4 Mn by 2032, reflecting strong market growth at an 8.7% CAGR.



3. Which end-user segment has the largest growth opportunity?

Fertility clinics remain the largest revenue generators, but hospitals are the fastest-growing end-user segment, driven by the addition of reproductive health units in multi-specialty facilities, particularly in Asia Pacific.



4. How will market development trends evolve over the next five years?

The market will pivot further toward AI-embedded embryo incubation and non-invasive diagnostics, supported by evolving regulatory approvals and increasing health-tech partnerships.



5. What is the nature of the competitive landscape and challenges in the Infertility Devices Market?

The landscape features established device manufacturers and emerging digital-health startups. Key challenges include high regulatory complexity, reimbursement variability, and the need for clinical validation of new technologies.



6. What go-to-market strategies are commonly adopted in the Infertility Devices Market?

Market players focus on strategic partnerships with fertility networks, localized manufacturing expansions, and integrated software-hardware solutions to enhance market penetration and support business growth.

Get This Report in Japanese Language -不妊治療機器市場

Get This Report in Korean Language -불임 치료 기기 시장

Read More Articles Related to this Industry -

Nanofiber Applications in Medical Devices: Revolutionizing Healthcare

Camera Modules in Medical Devices: Revolutionizing Diagnostics and Treatment



About Author:              

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)